Topic

New York

A collection of 516 issues

Renewing Mycapssa (Octreotide) Approval with Cigna in New York: Complete Timeline & Documentation Guide

Answer Box: Renewing Mycapssa with Cigna in New York To renew Mycapssa (octreotide) approval with Cigna in New York: Submit renewal documentation 1-4 weeks before your current authorization expires. You'll need recent IGF-1 lab results showing biochemical control, an updated endocrinologist note confirming ongoing response, and proof of

How to Get Increlex (Mecasermin) Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Increlex (Mecasermin) Covered by Cigna in New York Yes, Cigna covers Increlex (mecasermin) with prior authorization for severe primary IGF-1 deficiency in children age 2+. The fastest path: Your pediatric endocrinologist submits a prior authorization request with lab results (IGF-1 ≤-3.0 SD, normal/elevated GH), growth

How to Get Rebif (Interferon Beta-1a) Covered by UnitedHealthcare in New York: Timeline, Appeals, and Documentation Guide

Quick Answer: Getting Rebif Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Rebif (interferon beta-1a) in New York, typically taking 1-5 business days for standard requests. Submit through OptumRx's electronic portal with complete documentation: MS diagnosis, MRI results, relapse history, liver function tests, and CBC.

How to Get Xenpozyme Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization Guide

Answer Box: Quick Start Guide Xenpozyme (olipudase alfa-rpcp) requires prior authorization from all Blue Cross Blue Shield plans in New York. Success depends on three key elements: confirmed ASMD diagnosis with genetic testing, comprehensive baseline assessments, and specialist involvement. First step today: Verify your specific BCBS plan's formulary

How to Get Xospata (gilteritinib) Covered by Humana in New York: Prior Authorization Forms, Appeals Timeline, and Success Tips

Quick Answer: Xospata (gilteritinib) requires prior authorization from Humana in New York. Your hematologist must submit clinical documentation proving FLT3 mutation, relapsed/refractory AML status, and medical necessity. If denied, you have 65 days to appeal and can use New York's external review process. Start by confirming your

How to Get Qalsody (tofersen) Covered by Blue Cross Blue Shield in New York: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Qalsody (tofersen) Covered by Blue Cross Blue Shield in New York Quick Path to Approval: Blue Cross Blue Shield in New York requires prior authorization for Qalsody with documented SOD1 mutation, ALS diagnosis by a neurologist, and ALSFRS-R/NfL baseline data. If denied, file internal appeal within

How to Get Ofev (nintedanib) Covered by Humana in New York: Prior Authorization, Appeals, and Formulary Alternatives

Answer Box: Getting Ofev (nintedanib) Covered by Humana in New York Ofev (nintedanib) requires prior authorization from Humana Medicare plans in New York. Your fastest path to approval: 1) Have your pulmonologist submit a prior authorization request with IPF/SSc-ILD diagnosis, HRCT results, and pulmonary function tests through Humana'

How to Get Opzelura (ruxolitinib cream) Covered by Aetna CVS Health in New York: Complete Forms & Appeals Guide

Answer Box: Getting Opzelura Covered by Aetna CVS Health in New York Opzelura (ruxolitinib cream) requires prior authorization from Aetna CVS Health in New York. The fastest path to approval: (1) Your doctor completes Aetna's Medical Exception/Prior Authorization form with documentation of failed topical steroids or calcineurin

How to Get Kuvan (Sapropterin) Covered by Humana in New York: Appeals, Forms & Medical Necessity Criteria

Answer Box: Humana requires prior authorization for Kuvan (sapropterin dihydrochloride) with documented PKU diagnosis, 30% phenylalanine reduction during trial, and ongoing specialist oversight. Start by having your metabolic specialist submit a PA request through Humana's provider portal with baseline/post-treatment labs, dietary compliance records, and medical necessity letter.

Getting Kymriah (tisagenlecleucel) Covered by Blue Cross Blue Shield in New York: Prior Authorization, Appeals, and Cost Relief

Answer Box: Your Path to Kymriah Coverage in New York Blue Cross Blue Shield (BCBS) in New York requires prior authorization for Kymriah (tisagenlecleucel) in 2024. To get coverage, your doctor must submit clinical documentation showing FDA-approved indication, prior treatment failures, and CD19 positivity. If denied, you have 45 days